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Abstract. 
 
During limb development, chondrocytes lo-
cated at the epiphyseal tip of long bone models give rise 
to articular tissue, whereas the more numerous chon-
drocytes in the shaft undergo maturation, hypertrophy, 
and mineralization and are replaced by bone cells. It is 
not understood how chondrocytes follow these alterna-
tive pathways to distinct fates and functions. In this 
study we describe the cloning of C-1-1, a novel variant 
 
of the 
 
ets
 
 transcription factor 
 
ch
 
-ERG. C-1-1 lacks a 
 
short 27–amino acid segment located 
 
z
 
80 amino acids 
upstream of the 
 
ets
 
 DNA binding domain. We found 
that in chick embryo long bone anlagen, C-1-1 expres-
sion characterizes developing articular chondrocytes, 
whereas 
 
ch
 
-ERG expression is particularly prominent 
in prehypertrophic chondrocytes in the growth plate. To 
analyze the function of C-1-1 and 
 
ch
 
-ERG, viral vectors 
were used to constitutively express each factor in devel-
oping chick leg buds and cultured chondrocytes. We 
found that virally driven expression of C-1-1 main-
tained chondrocytes in a stable and immature pheno-
type, blocked their maturation into hypertrophic cells, 
and prevented the replacement of cartilage with bone. 
It also induced synthesis of tenascin-C, an extracellular 
matrix protein that is a unique product of developing 
articular chondrocytes. In contrast, virally driven ex-
pression of 
 
ch
 
-ERG signiﬁcantly stimulated chondro-
cyte maturation in culture, as indicated by increases in 
alkaline phosphatase activity and deposition of a min-
eralized matrix; however, it had modest effects in vivo. 
The data show that C-1-1 and 
 
ch
 
-ERG have diverse bi-
ological properties and distinct expression patterns dur-
ing skeletogenesis, and are part of molecular mecha-
nisms by which limb chondrocytes follow alternative 
developmental pathways. C-1-1 is the ﬁrst transcription 
factor identiﬁed to date that appears to be instrumental 
in the genesis and function of epiphyseal articular chon-
drocytes.
Key words: transcription factor ERG • articular 
chondrocytes • growth plate chondrocytes • limb devel-
opment • tenascin-C
 
Introduction
 
During limb skeletogenesis, chondrocytes follow two dis-
tinct developmental pathways to two distinct fates and
functions. The relatively few chondrocytes present at the
epiphyseal extremity of long bone anlagen develop into
permanent articular chondrocytes, which give rise to artic-
ular cartilage, produce abundant extracellular matrix, and
maintain normal joint function throughout life (Mitrovic,
1977, 1978; Archer et al., 1994; Pacifici, 1995). In contrast,
the much more numerous chondrocytes constituting the
shaft of the long bone anlagen are transient, become or-
ganized into growth plates, undergo maturation, hyper-
trophy, mineralization and apoptosis, and are eventu-
 
ally replaced by bone cells via endochondral ossification
(Howlett, 1979; Hunziker, 1994). Both populations of
chondrocytes are of obvious crucial importance for skele-
togenesis and skeletal function. By organizing and main-
taining the articular tissue, articular chondrocytes allow
the joints and associated structures to exert their im-
portant biomechanical roles and permit normal body
movements throughout life. Likewise, by undergoing pro-
liferation, maturation, and hypertrophy, the growth plate
chondrocytes allow each skeletal element to grow in
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length and width, contribute to the determination of shape
and orientation of the elements, and permit the normal re-
placement of hypertrophic mineralized cartilage with de-
finitive bone and bone marrow.
Given the fundamental roles played by articular and
growth plate chondrocytes in skeletal organization and
function, it is not surprising that there is ever increasing in-
terest in them. This has led to the identification of a num-
ber of molecules with important roles in the development,
behavior, and function of growth plate chondrocytes, in-
cluding signaling molecules, growth factors, and transcrip-
tion factors (Colvin et al., 1996; Vortkamp et al., 1996;
Enomoto-Iwamoto et al., 1998; Koyama et al., 1999). In
contrast, we remain largely ignorant about the mecha-
nisms leading to the development of articular chondro-
cytes, particularly at the molecular level. Thus, we know
little about how the numerically few presumptive articular
chondrocytes emerging at the epiphyseal tip of long bone
anlagen: (a) acquire their permanent phenotype, (b) es-
cape the maturation and ossification process followed by
the more numerous growth plate chondrocytes, (c) trans-
mit these properties to their progeny, and (d) remain func-
tional throughout life. Detailed information on articular
chondrocyte development and function would not only be
of intrinsic biological interest, but is also likely to have im-
portant medical ramifications for joint diseases such as os-
teoarthritis, in which the articular chondrocyte phenotype
is altered and joint function is progressively lost (Hamer-
man, 1989).
It was shown recently that the transcription factor ERG
is expressed at sites of future joint development in the
early chick limb (Ganan et al., 1996; Macias et al., 1997).
ERG belongs to the 
 
ets
 
 family of transcription factors,
which are highly conserved and are involved in a variety of
biological processes (Rao et al., 1987; Wasylyk et al., 1993,
1998). Every family member contains the ETS domain, a
conserved 85–amino acid region that mediates binding to
 
ets
 
 motifs containing the core recognition sequence 5
 
9
 
-
GGAA-3
 
9
 
. Three major splice variants of mammalian
ERG have been cloned (Duterque-Coquillaud et al., 1993;
Prasad et al., 1994). The longest variant, termed ERG-3 or
p55
 
erg
 
, is 
 
z
 
480 amino acids long. In comparison, ERG-2
lacks a short 24–amino acid segment in the central portion
of the protein upstream of the ETS domain, and ERG-1/
p49 
 
erg
 
 lacks both the 24–amino acid segment and an adja-
cent 5
 
9
 
 27–amino acid segment. All ERG variants bind
DNA and transactivate reporter constructs containing 
 
ets
 
response elements, but it is not known whether they have
different functions in vivo (Duterque-Coquillaud et al.,
1993; Prasad et al., 1994). One avian ERG, 
 
ch
 
-ERG, has
been cloned to date (Dhordain et al., 1995) and corre-
sponds to mammalian ERG-3/p55
 
erg
 
.
Based on the finding that 
 
ch
 
-ERG is expressed at sites
of joint formation in early chick embryo limbs, we tested
the hypothesis in this study that 
 
ch
 
-ERG may be involved
in articular chondrocyte development. We report here that
in addition to 
 
ch
 
-ERG, chick limb cartilages express a
novel ERG variant we termed C-1-1, which lacks only the
27–amino acid segment. We found by in situ hybridization,
immunohistochemistry and quantitative RT-PCR that
C-1-1 is preferentially expressed in developing articular
chondrocytes, whereas 
 
ch
 
-ERG expression is prominent in
 
prehypertrophic chondrocytes in the growth plate of de-
veloping long bones. Experimental analyses in vivo and in
vitro reveal that C-1-1 and 
 
ch
 
-ERG have very distinct bio-
logical properties and may thus play important roles in the
behavior and functional diversification of limb chondro-
cytes.
 
Materials and Methods
 
Cartilage Tissue Isolation and RT-PCR
 
Samples of articular cartilage layer and underlying growth plate were mi-
crosurgically isolated from day 17 chick embryo tibiotarsus or femurs.
Care was taken to remove adhering perichondrial and connective tissues
and obtain as homogeneous cartilaginous tissue as possible. RNA was iso-
lated by the guanidium isothiocyanate method (Iwamoto et al., 1993b)
and processed for standard RT-PCR
 
1
 
 as described (Enomoto-Iwamoto et
al., 1998). In brief, 1 
 
m
 
g of RNA was reverse transcribed with Superscript
reverse transcriptase (GIBCO BRL) and random hexamers, and amplifi-
cation was carried out with Elongase (GIBCO BRL) for 30 cycles (95
 
8
 
C
for 10 s and 60
 
8
 
C for 1 min) with the following 
 
ch
 
-ERG sense and anti-
sense primers (indicated as primer A and primer B in Fig. 1 B, respec-
tively): 5
 
9
 
-CGAAGAGTTATTGTGCCAGC and 3
 
9
 
-GGCACTGTTGA-
AGATGATGGT. PCR products were separated by 2% agarose gel
electrophoresis. PCR products subcloned into pCRII vector (Invitrogen)
were sequenced on both strands by an automated DNA sequencer.
Quantitative RT-PCR was carried out using the one-step TaqMan EZ
RT-PCR kit and Prism 7700 sequence detection system according to man-
ufacturer’s protocols (PE Biosystems). 0.5-
 
m
 
g aliquots of RNA isolated
from the above tissue samples were reverse transcribed and amplified us-
ing r
 
Tth
 
 DNA polymerase and the following primers and TaqMan probes:
for 
 
ch
 
-ERG, 5
 
9
 
-ACTCAGGCCGAGCTATAACG, 3
 
9
 
-TGATCTCCTC-
GCTTGCTCA, and TacMan probe 5
 
9
 
-FAM-CTCCACGGTTAATG-
CATGCTAGAAA-TAMRA-3
 
9
 
; for C-1-1, 5
 
9
 
-CGCAGATATCCTCCT-
GTCACA, 3
 
9
 
-TGATCTCCTCGCTTGCTCATA, and TacMan probe
5
 
9
 
-FAM-ACTACCTCAGAGAGAGAGGAGCCACTTT-TAMRA-3
 
9
 
.
Data were normalized to 18S ribosomal RNA simultaneously measured in
each sample with the following primers: 5
 
9
 
-CGGCTACCACATCCAAG-
GAA, 3
 
9
 
-GCTGGAATTACCGCGGCT, and TaqMan probe 5
 
9
 
-JOE-
TGCTGGCACCAGACTTGCCCTC-TAMRA-3
 
9
 
.
 
In Situ Hybridization
 
This procedure was carried out as described (Koyama et al., 1995) with
some modifications. Tissue sections were pretreated with 1 
 
m
 
g/ml protein-
ase K for 1 min at room temperature and acetylated. Sections were hy-
bridized with 
 
35
 
S-UTP–labeled antisense or sense probes (
 
z
 
1 
 
3
 
 10
 
6
 
 DMP/
section) at 50
 
8
 
C for 16 h, washed, treated with 20 
 
m
 
g/ml RNase A for 30
min, washed three times with 0.1
 
3
 
 SSC at 50
 
8
 
C for 10 min/wash, coated
with Kodak NTB3 photographic emulsion, and exposed for 7–14 d. Alter-
natively, sections were hybridized with digoxigenin-labeled riboprobes
synthesized according to manufacturer’s directions (Boehringer), washed
as above, and developed with Nitroblue Tetrazolium, 5-bromo-4-chloro-
3-indoyl-phosphate substrate solution. The chick type II and type X col-
lagen cDNA clones used were described previously (Koyama et al., 1995).
To prepare a 
 
ch
 
-ERG–specific probe, oligomers containing an EcoRI site
at 5
 
9
 
 end and HindIII site at 3
 
9
 
 end were used for PCR of the 81-bp region
present in 
 
ch
 
-ERG. The PCR product was then subcloned into pGEM3Z
vector. A 
 
ch
 
-ERG/C-1-1 probe was prepared by amplification of nu-
cleotide 429–901 region and subcloning into pGEM-T easy vector
(Promega).
 
Immunohistochemistry
 
This procedure was carried out as described with some modifications (Shi-
mazu et al., 1996). For detection of ERG proteins, paraffin sections of
limb long bone cartilaginous anlagen were deparaffinized, rehydrated and
treated with 1 
 
m
 
g/ml proteinase K for 10 min at 37
 
8
 
C to unmask nuclear
 
1
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antigens. Sections were then incubated for 2 h at room temperature with
different dilutions of primary antibodies which were: (a) rabbit affinity-
purified antibodies to human ERG-1/ERG-2 (Santa Cruz Biotechnology;
these antibodies cross-react with all variants of ERG and were originally
raised against a peptide corresponding to COOH terminus amino acids
344–363 of human ERG-1 that is present in every ERG variant and is
highly conserved among species); or (b) a rabbit antiserum specific for 
 
ch
 
-
ERG that we prepared. Peptide PLPHLTSDDVDKALQNSPRLMH
corresponding to the 81-bp region present in 
 
ch
 
-ERG only was injected
three times in different rabbits. Specificity of the antiserum used in this
study (antiserum no. 46200) was verified by ELISA assays. After exten-
sive rinsing, bound antibodies were revealed by the biotin-avidin-peroxi-
dase detection method, Histofine (Nichirei), or by the biotin-avidin-
 
b
 
-galac-
tosidase method (Lim and Chae, 1989; Koyama et al., 1999). Slides were
counterstained with fast green or left unstained and were mounted and
viewed by microscopy.
In experiments monitoring changes in tenascin-C distribution, concen-
trated RCAS-C-1-1 or RCAS-
 
ch-
 
ERG virus was first injected in the leg
bud of stage 22–23 chick embryos; contralateral limb bud was left un-
treated and served as control. Embryos were allowed to develop until day
10–11, and both legs were dissected and fixed with 4% paraformaldehyde
in PBS for 24 h. Serial 8-
 
m
 
m paraffin sections from infected and control
legs were mounted on the same glass slides so that the immunostaining re-
sults were directly comparable. Sections were treated with 5 mg/ml hyal-
uronidase in blocking solution (10% normal goat serum) for 3 h at 37
 
8
 
C to
remove matrix components and facilitate antibody penetration. Sections
were then incubated in fresh blocking solution containing a 1:200 dilution
of monoclonal antibody M1 against chick tenascin-C (Chiquet and Fam-
brough, 1984) for 16 h at room temperature. After rinsing, sections were
incubated with a 1:250 dilution of rhodamine-conjugated goat anti–mouse
IgGs for 1 h, rinsed again, and mounted with 60% glycerol. Sections were
viewed and photographed with a Zeiss microscope equipped with epifluo-
rescence.
 
RCAS Constructs and Limb Implantation
 
Full-length 
 
ch
 
-ERG and C-1-1 cDNAs were isolated from a day 17 chick
embryo sternal cartilage 
 
l
 
ZAP (Stratagene) cDNA library that we pre-
pared. Coding sequences were amplified by PCR (primers: 5
 
9
 
-ATCT-
TGATCACATTATGGCAAGC and 3
 
9
 
-CACTTAGTAGTAGGTGCC-
AAGATGG), resequenced to confirm coding fidelity, and subcloned into
the ClaI site of RCAS(A) retroviral vector (Hughes et al., 1987). The re-
sulting RCAS-C-1-1 and RCAS-
 
ch
 
-ERG plasmids were transfected into
germ-free SPAFAS chick embryo fibroblasts by FuGENE6 transfection
reagent (Boehringer) to produce viral particles; companion cultures were
transfected with insert-less RCAS plasmid to produce insert-less control
virus. Viral particles were isolated and concentrated from fibroblast con-
ditioned media by ultracentrifugation (Enomoto-Iwamoto et al., 1998).
For in vivo experiments, concentrated virus (RCAS, RCAS-C-1-1, or
RCAS-
 
ch
 
-ERG) was injected in the vicinity of skeletal mesenchymal con-
densations in stage 22–23 germ-free chick embryo leg bud. Embryos were
returned to the incubator and examined at later times. Alternatively, a
small fragment of virally infected fibroblast monolayer was implanted into
the mesenchyme of stage 22–23 chick embryo leg bud in the vicinity of
mesenchymal condensations (Koyama et al., 1996), and embryos were ex-
amined at later time points. Viral injection and fibroblast implantation
gave comparable results.
 
Chondrocyte Cultures, Immunoblots, and
Northern Blots
 
Chondrocytes were isolated from the caudal one-third portions of day 17–
18 chick embryo sterna (Gibson and Flint, 1985; Iwamoto et al., 1993b).
The freshly isolated cells were infected with 
 
ch
 
-ERG, C-1-1 or insert-less
RCAS viruses, and maintained in serum-containing monolayer cultures
for up to 5 wk with weekly subculturing. To insure that the 
 
ch
 
-ERG- and
C-1-1 viruses had maintained coding fidelity throughout the culture pe-
riod, RNA was isolated from cultures of different ages and subjected to
RT-PCR, using primers encompassing the alternative-spliced 81-bp re-
gion. The sense primer used, 5
 
9
 
-CTCGCGTACCACTGTGGCAT, corre-
sponds to a sequence between the splice site and the cloning site of the
RCAS vector, and the antisense primer used, 3
 
9
 
-TCCGACAGAAGCTC-
CAGTAGGAA, corresponds to nucleotides 1,005–1,021 common to both
 
ch
 
-ERG and C-1-1. RNA isolation, Northern and Western blot proce-
dures, cDNA probes, immunocytochemistry, and histochemical detection
of mineral used for analyses of chondrocyte culture were carried out as
described (Iwamoto et al., 1993b; Koyama et al., 1995). Nuclei were iso-
lated from monolayer cultures by slight modifications of previous meth-
ods (Kawabe et al., 1999). In brief, cells were rinsed and scraped into PBS
at 4
 
8
 
C, pelleted by centrifugation, resuspended in cold hypotonic buffer
(10 mM Hepes, pH 7.5, 1.5 mM MgCl
 
2
 
, 10 mM KCl, 0.5 mM DTT, 5 mM
EDTA, and 5 mM EGTA), passed through a 22 1/2–G needle 20 times,
and finally spun at 3,500 rpm. Pellets were suspended in Hepes buffer con-
taining 25% glycerol, shaken for 30 min at 4
 
8
 
C, and centrifuged; the re-
sulting supernatants represented nuclear extracts and were processed for
Western blot analysis of 
 
ch
 
-ERG and C-1-1 content using the antisera de-
scribed above.
RNA isolated from chondrocyte cultures was processed for Northern
blot analysis using chick tenascin-C and aggrecan cDNA clones as de-
scribed previously (Pacifici et al., 1993).
 
Results
 
Cloning of C-1-1 and Expression Patterns of ch-ERG 
and C-1-1
 
In the first set of experiments, we asked whether 
 
ch
 
-ERG
is expressed at late stages of chick limb skeletogenesis
and whether 
 
ch
 
-ERG variants homologous to mammalian
variants occur in chick and are expressed in cartilage. To
this end, RNA was isolated from the cartilaginous femur
or tibiotarsus of day 17 chick embryos and was processed
for reverse transcription polymerase chain reaction (RT-
PCR; Fig. 1 A). At this stage of development, the femur
and tibiotarsus contain (a) a well-formed epiphysis dis-
playing a thick articular chondrocyte layer and an overlay-
ing thin fibrocartilage layer facing the synovial cavity, and
(b) a long metaphyseal-diaphyseal region with growth
plate chondrocytes undergoing maturation, hypertrophy,
and endochondral ossification (Howlett, 1979; Pacifici,
1995). The PCR primers used were from sequences up-
stream and downstream of the 81- and 72-bp segments al-
ternatively spliced in mammals (Fig. 1 B). We obtained
two products of 473 and 392 bp (Fig. 1 A). Sequence anal-
ysis revealed that the 473-bp product encoded the previ-
ously described 
 
ch
 
-ERG (Fig. 1 C), while the 392-bp prod-
uct encoded an alternative and novel variant lacking the
81-bp segment only (Fig. 1, B and C). We named this avian
variant C-1-1. No additional 
 
ch
 
-ERG variants were ob-
tained by 5
 
9
 
 and 3
 
9
 
 RACE analysis of cartilage samples
(not shown).
To identify the chondrocyte population(s) expressing
 
ch
 
-ERG and/or C-1-1, longitudinal sections of day 17
chick embryo tibiotarsus were processed for in situ hybrid-
ization (Koyama et al., 1995). We used a common probe
that hybridizes to both C-1-1 and 
 
ch
 
-ERG, and a probe
which is 
 
ch
 
-ERG specific and encodes the 81-bp segment
present only in 
 
ch
 
-ERG. The common probe produced a
strong hybridization signal in the articular chondrocyte
layer and in the prehypertrophic zone of growth plate (Fig.
1 D, left panel). Signal was particularly strong in chondro-
cytes located along the border between the articular layer
and overlaying fibrocartilage, but there was no signal in
the fibrocartilage layer itself (Fig. 1 D, left panel, arrow-
heads). In comparison, the 
 
ch
 
-ERG–specific probe pro-
duced a strong signal only in the prehypertrophic zone
(Fig. 1 D, right panel), suggesting that the signal in articu-
lar cartilage layer was largely due to C-1-1. Low signal was
seen in the proliferative and hypertrophic zones with ei- 
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ther probe (Fig. 1 D). Sense probes produced no specific
hybridization signal (not shown).
To obtain more quantitative data, RNA was isolated
from the articular layer and from the underlying growth
plate of day 17 tibiotarsus and processed for quantitative
RT-PCR, using the single-tube single-enzyme system and
internal normalization to 18S ribosomal RNA. We found
that C-1-1 and 
 
ch
 
-ERG transcripts were present in both
samples (Table I). However, C-1-1 transcripts were sev-
eral fold more abundant in the articular cartilage sample
than growth plate sample, while 
 
ch
 
-ERG transcript lev-
els were similar in both samples. The C-1-1/
 
ch
 
-ERG ratio
 
was 
 
z
 
2.8 in articular cartilage and 0.8 in growth plate
(Table I).
To verify and extend these findings, we processed longi-
tudinal sections of day 17–18 tibiotarsus for immunohis-
tochemistry (Fig. 2), using a commercially available antise-
rum that reacts with every ERG variant (anti–
 
ch
 
-ERG/
C-1-1) and an antiserum specific for 
 
ch
 
-ERG that we pre-
pared (anti–
 
ch
 
-ERG). The common 
 
ch
 
-ERG/C-1-1 antise-
rum produced specific nuclear staining in both articular
(Fig. 2 A) and prehypertrophic chondrocytes (Fig. 2, B
and F); as also seen by in situ hybridization, expression
was particularly strong in chondrocytes at the articular-
fibrocartilage border (Fig. 2 A, arrowhead). This antise-
rum did not stain chondrocytes in the proliferative and hy-
pertrophic zones (Fig. 2, E and G) and fibrocartilage cells
(Fig. 2 A). In comparison, the 
 
ch
 
-ERG–specific antibodies
produced strong nuclear staining in prehypertrophic chon-
drocytes (Fig. 2 D) but much less staining in articular
chondrocytes (Fig. 2 C). Other growth plate zones exhib-
ited barely visible staining (not shown).
Taken together, the above data show that C-1-1 expres-
sion characterizes chondrocytes in the developing articular
cartilage layer, while 
 
ch
 
-ERG is preferentially produced
by prehypertrophic chondrocytes in the growth plate.
 
Biological Activities of ch-ERG and C-1-1 In Vivo
 
To determine the biological properties and possible func-
tions of 
 
ch
 
-ERG and C-1-1 in skeletogenesis, we ectopi-
cally expressed these factors in early chick limb buds using
the replication-competent retroviral vector RCAS (Hughes
et al., 1987) and determined the effects on long bone de-
velopment at later stages. Accordingly, we injected con-
centrated 
 
ch
 
-ERG or C-1-1 virus in the anterior mesen-
chymal region of the leg bud in stage 22–23 (day 3.5–4.0)
chick embryos; alternatively, we implanted a small pellet
of fibroblasts producing 
 
ch
 
-ERG or C-1-1 viral particles in
the same region. As control, companion embryos were im-
planted in the same position with insert-less RCAS virus
or fibroblasts producing insert-less virus. Eggs were rein-
cubated until day 10 (stage 36) of embryogenesis, and the
effects of misexpression of 
 
ch
 
-ERG or C-1-1 were deter-
mined by histology and in situ hybridization.
These procedures resulted in a high frequency of infec-
tion of the developing tibiotarsus. In control day 10 em-
bryos, the tibiotarsus displayed characteristic histological
features, including a proximal flat-shaped articulating epiph-
ysis (Fig. 3 A, arrowhead), a distal round-shaped articulat-
ing epiphysis (Fig. 3 B), and a long metaphyseal-diaphy-
seal shaft with growth plate chondrocytes undergoing
maturation and ossification (Fig. 3 A, arrows). The di-
aphysis contained hypertrophic mineralizing cartilage, en-
dochondral bone, and invading marrow (Fig. 3 E), and was
surrounded by a well-formed intramembranous bone col-
Figure 1. Cloning and analyses of C-1-1 and ch-ERG. (A) Elec-
trophoretic pattern of RT-PCR products with RNA isolated
from the entire day 17 chick embryo tibiotarsus. (B) Schematic
representation of ch-ERG and C-1-1 showing the location of the
alternatively spliced 81- and 72-bp segments located z200 bp up-
stream of the ETS DNA-binding domain. Location of primers
used for RT-PCR is indicated. (C) Nucleotide and predicted
amino acid sequences of the alternatively spliced region and
flanking segments. Note that an amino acid substitution from G
to R is predicted to occur in C-1-1 as a result of splicing. (D) In
situ hybridization analysis of ch-ERG and C-1-1 gene expression
in day 17 chick embryo tibiotarsus, using a common probe hy-
bridizing to both ch-ERG and C-1-1 (left panel) or a probe spe-
cific for ch-ERG (right panel). Positive hybridization signal ap-
pears as dark blue-purple. Arrowheads point to strongly positive
chondrocytes located along the cartilage-fibrocartilage (FC) bor-
der. Bar, 35 mm.
Table I. Determination of C-1-1 and ch-ERG Expression 
Levels by Quantitative RT-PCR
Tissue C-1-1 6 SD ch-ERG 6 SD C-1-1/ch-ERG
Articular cartilage 146 6 33.0 52 6 16.3 2.81
Growth plate 35 6 7.5 44 6 4.2 0.80Iwamoto et al. ERG Factors and Chondrocyte Diversification 31
lar (Fig. 3 E, arrowheads). When we examined ch-ERG vi-
rus-infected embryos, relatively few effects were seen. A
slight longitudinal shortening of tibiotarsus was obtained
in some cases (2/7). However, the overall histological or-
ganization of tibiotarsus was normal, and the diaphysis
contained seemingly normal hypertrophic cartilage, endo-
chondral and intramembranous bone (Fig. 3 G, arrow-
heads), and invading marrow. In sharp contrast, when we
examined C-1-1 virus-infected embryos, we found that
the tibiotarsus was significantly shorter and abnormally
shaped compared with control (5/6) (Fig. 3, C and D).
The epiphyses were severely abnormal; paradoxically, the
proximal epiphysis was elongated (Fig. 3 C) and the distal
one was broad and flatter (Fig. 3 D); that is, the reverse of
control epiphyses. In addition, the metaphyseal-diaphy-
seal shaft displayed no hypertrophic cartilage (Fig. 3 C, ar-
row), no endochondral bone, no marrow, and no in-
tramembranous bone collar (Fig. 3 F, arrowheads).
To further assess the effects of C-1-1 misexpression, lon-
gitudinal sections of day 10 control and C-1-1–infected legs
were processed for in situ hybridization. In control tib-
iotarsus, expression of the cartilage characteristic type II
collagen gene was strong throughout the cartilaginous tis-
sues (Fig. 4 A) and type X collagen gene expression was
restricted to hypertrophic chondrocytes (Fig. 4 B, arrows).
In C-1-1–infected tibiotarsus, type II collagen expression
was strong as in control (Fig. 4 D), but type X collagen
gene expression was undetectable (Fig. 4 E), confirming
that chondrocyte maturation had been halted. To corre-
late these gene expression patterns to viral distribution
and C-1-1 misexpression, companion longitudinal sections
Figure 2. Immunohistochemical localization of ERG proteins.
Longitudinal sections of day 17–18 tibiotarsus were processed for
immunodetection of ERG proteins, using ch-ERG/C-1-1 antise-
rum (A, B, and E–G) or ch-ERG–specific antiserum (C and D).
Histochemical detection of antibodies was by the peroxidase
method followed by fast green counterstaining (A–D) or b-galac-
tosidase method without counterstaining (E–G). Positively stain-
ing nuclei appear as dark blue or brown. See text for further
details. Arrowhead in A points to strongly immunopositive chon-
drocytes located along the cartilage-fibrocartilage (FC) border.
Bars: (A–D) 35 mm; (E–G) 30 mm.
Figure 3. Functional analyses of C-1-1 and ch-ERG roles in
chondrocyte and long bone development. Retroviral particles en-
coding C-1-1 or ch-ERG were implanted in stage 22–23 chick em-
bryo leg buds in ovo; insert-less retroviral particles were im-
planted in companion embryos as control. Embryos were
reincubated and examined on day 10 by histology. (A and B)
Proximal one-third portion and distal epiphysis of control tibio-
tarsus, respectively. Note the characteristic flat proximal articular
epiphysis (A, arrowhead) and the round distal epiphysis (B), and
the long metaphyseal shaft with chondrocytes undergoing matu-
ration and hypertrophy (arrows in A). (C and D) Entire C-1-1 vi-
rus-infected tibiotarsus. These pictures were taken at the same
magnification as (A and B) and thus show that the C-1-1 tibiotar-
sus is nearly half the length of the control. Both proximal and dis-
tal epiphyses are severely malformed, and the metaphyseal-
diaphyseal shaft (arrow in C) lacks a normal growth plate and
hypertrophic chondrocytes. (E) Diaphyseal portion of control tib-
iotarsus viewed at higher magnification; it displays mineralizing
post-hypertrophic chondrocytes, invading bone and marrow pre-
cursor cells, and a well-developed intramembranous bone collar
(arrowheads). (F) Diaphyseal portion of C-1-1 tibiotarsus in
which hypertrophic chondrocytes, marrow invasion and a bone
collar (arrowheads) are all absent. (G) Diaphyseal portion of ch-
ERG virus-infected tibiotarsus. Note that it closely resembles
control tibiotarsus and contains hypertrophic chondrocytes and a
bone collar (arrowheads). Bars: (A–D) 1.5 mm; (E–G) 60 mm.The Journal of Cell Biology, Volume 150, 2000 32
which are characteristic of articular and immature chon-
drocytes, while ch-ERG should not. Thus, we determined
whether C-1-1 and ch-ERG differentially affect gene ex-
pression of tenascin-C, an extracellular matrix molecule
produced by articular and immature chondrocytes but not
produced by maturing growth plate chondrocytes (Pacifici
et al., 1993; Savarese et al., 1996). In this respect, tenas-
cin-C is a unique and rare phenotypic marker, given that
articular and growth plate chondrocytes otherwise share
numerous phenotypic traits, including collagens II, IX, and
XI, link protein, aggrecan, hyaluronan, and others.
To test the above prediction in vivo, C-1-1 or ch-ERG
virus was again injected in the leg bud of stage 22–23 chick
embryos; contralateral leg bud was not injected and served
as control. On day 10–11 of embryogenesis, legs were dis-
sected, fixed, and embedded in paraffin; the resulting
longitudinal serial sections were processed for immuno-
histochemistry, using the chick tenascin-C monoclonal
antibody M1 (Chiquet and Fambrough, 1984). To com-
pare the results directly, sections from infected and control
legs were mounted on the same microscopic slides and si-
multaneously processed for immunohistochemistry. In this
series of virus injections, both the tibiotarsus and metatar-
sal elements were infected. In control uninfected ele-
ments, tenascin-C displayed a characteristic distribution;
it was confined to most epiphyseal developing articular
chondrocytes (Fig. 6, A and C, arrows) and was largely ab-
sent from the long underlying growth plate (Pacifici et al.,
1993). A similar distribution was seen in ch-ERG virus-
infected elements (not shown). In sharp contrast, tenascin-C
staining in C-1-1 virus-infected elements was both stronger
and more widely distributed. In the abnormally shaped
tibiotarsus, tenascin-C staining occupied a large portion of
the epiphysis-metaphysis and was quite strong; it then de-
creased in the remainder of the shaft (Fig. 6 B). In the sim-
ilarly abnormal metatarsal element, tenascin-C staining
were hybridized with radiolabeled ch-ERG/C-1-1 probe
and exposed for a short and identical period of time so
that hybridization signal levels were directly comparable.
In control specimens, hybridization signal was relatively
weak (given the short exposure; Fig. 4 C), whereas in
C-1-1–infected specimens signal was extremely strong and
present throughout the tibiotarsus and adjacent connec-
tive tissues (Fig. 4 F).
The severe phenotypic changes in the tibiotarsus of
C-1-1–infected embryos were limited to the tibiotarsus it-
self, did not reflect systemic changes, and did not occur in
neighboring uninfected skeletal elements. For example,
the fibula next to the C-1-1–infected tibiotarsus shown in
Fig. 3, C and D, above had remained uninfected and was
morphologically and histologically normal (Fig. 5 A). It
displayed abundant type II collagen transcripts in each
region (Fig. 5 B) and abundant type X collagen transcripts
in its hypertrophic diaphysis (Fig. 5 C), and contained
low normal levels of ch-ERG/C-1-1 transcripts, whereas
these transcripts were extremely abundant in the sur-
rounding virus-infected perichondrial-mesenchymal tis-
sues (Fig. 5 D).
Together, the results show that the biological activities
of C-1-1 and ch-ERG are very different. C-1-1 appears to
be a potent inhibitor of chondrocyte maturation and hy-
pertrophy; this indicates that one function of this factor is
to maintain chondrocytes in an immature and develop-
mentally stable state, such as that displayed by articular
chondrocytes. Instead, ch-ERG appears to have modest
biological effectiveness.
C-1-1, but Not ch-ERG, Induces Tenascin-C Gene 
Expression In Vivo and In Vitro
Given the above conclusion, one would predict that C-1-1
should regulate and induce expression of phenotypic traits
Figure 4. In situ hybridiza-
tion analysis of gene expres-
sion in day 10 control (A–C)
and C-1-1 virus-infected
(D–F) tibiotarsus. (A and
D) Strong type II collagen
expression is present in
both  control (A) and C-1-1–
infected (D) tibiotarsus, indi-
cating that infection had no
obvious deleterious effects on
the differentiated phenotype
of chondrocytes. (B and E)
Type X collagen expression is
present only in control tissue
(B, arrows) but not in C-1-1
tissue (E), indicating that
chondrocyte hypertrophy had
been blocked. (C and F) Rel-
atively weak hybridization
signal for endogenous ch-
ERG/C-1-1 RNA is seen in control tissue (C), owing to the short exposure time used; in comparison, extremely strong signal is seen in
C-1-1–infected tissue (F), indicating presence of C-1-1–encoding virus throughout the cartilaginous tissue and adjacent connective tis-
sues. Note that about one-third of control tibiotarsus is shown in (A–C), whereas nearly the entire RCAS-C-1-1 tibiotarsus is shown in
(D–F). Bar, 200 mm.Iwamoto et al. ERG Factors and Chondrocyte Diversification 33
was actually detectable in each portion and was continu-
ously present from proximal epiphysis to distal epiphysis
(Fig. 6 D).
Tenascin-C can affect cell adhesion and morphology
(Erickson, 1993). It is noteworthy that the wider tenas-
cin-C distribution in C-1-1 virus-infected elements was ac-
companied by disturbances in the normal patterns of
characteristic chondrocyte morphologies. For example,
in control metatarsus the epiphyseal tenascin-C–positive
incipient articular chondrocytes were round in shape (Fig.
6 E) and were followed by tenascin-C–negative prolifera-
tive growth plate chondrocytes exhibiting their typical flat
and variously shaped morphology (Fig. 6 E; Howlett, 1979;
Pacifici et al., 1993). In the C-1-1 virus-infected element, a
clear transition from round to flat chondrocytes was ab-
sent; instead, most chondrocytes exhibited a roundish-to-
oval morphology (Fig. 6 F) and most of them were tenas-
cin-C rich (Fig. 6 D).
For an in vitro test of the hypothesis that C-1-1, but not
ch-ERG, regulates expression of tenascin-C, we isolated
resting chondrocytes from the caudal portion of day 17
chick embryo sternum, infected them with ch-ERG, C-1-1
or insert-less virus, and maintained them in culture for up
to 5 wk with weekly subculturing (passages 1–5). Sternal
chondrocytes were used because they can be isolated as
homogenous populations, whereas chondrocyte popula-
tions isolated from limb skeletal elements usually contain
contaminating perichondrial-fibroblastic cells (Gibson and
Flint, 1985; Iwamoto et al., 1993a). We found that virally
driven C-1-1 overexpression did lead to increased tenas-
cin-C mRNA levels at each passage, but ch-ERG overex-
pression did not (Fig. 7 A). Gene expression of aggrecan, a
chondrocyte characteristic matrix component, was not af-
fected by any of the viruses (Fig. 7 A, AG); the slight vari-
ations seen with passage number were not significant and
may reflect partial decrease in phenotypic expression over
time in culture. In good agreement with the RNA analysis,
immunocytochemistry on passage 2 cultures showed that
tenascin-C was hardly detectable in control cultures but
readily apparent in C-1-1–overexpressing cultures (Fig. 7
B). Previous studies showed that factors such as PTH/
PTHrP, Indian hedgehog (Ihh) and fibroblast growth fac-
tor-2, act as negative modulators of maturation in growth
plate chondrocytes (Iwamoto et al., 1995; Colvin et al.,
1996; Vortkamp et al., 1996). Interestingly, neither treat-
ment of sternal chondrocytes with any of these factors nor
virally driven Ihh overexpression led to increased expres-
sion of tenascin-C (not shown).
To verify that the ch-ERG and C-1-1 viruses had caused
the expected increases in ch-ERG and C-1-1 protein con-
tent, nuclear extracts were prepared from each of the
above cultures and processed for Western blot analysis; we
used the commercially available antiserum that reacts with
every ERG variant (anti–ch-ERG/C-1-1), and the antise-
rum specific for ch-ERG that we prepared (anti–ch-ERG).
We found that passage 1 chondrocytes infected with ch-
ERG or C-1-1 virus already contained several fold more
ch-ERG or C-1-1 protein than control cultures infected
with insert-less virus (Fig. 7 C). Note that endogenous lev-
els of ERG proteins in control cultures, though difficult to
document in Fig. 7 C, were appreciable by visual inspec-
tion and became readily apparent after longer develop-
ment of the blots (not shown).
Together, the above data show that C-1-1 can selectively
induce expression of tenascin-C, a unique product of ar-
ticular and immature chondrocytes, but ch-ERG can not.
In addition, C-1-1 misexpression and the concurrent in-
creases in tenascin-C distribution are accompanied by dis-
turbances in chondrocyte cytoarchitecture.
Opposite Effects of ch-ERG and C-1-1 on Alkaline 
Phosphatase and Mineralization
In a final set of experiments, we further compared the bio-
logical properties of ch-ERG and C-1-1. We reasoned that
if C-1-1 maintains chondrocytes in an immature state, it
should inhibit alkaline phosphatase activity that is strongly
expressed by mature hypertrophic chondrocytes (Leboy et
al., 1989); however, ch-ERG should have no effect. To test
this prediction, chondrocytes were isolated from the ce-
phalic maturing portion of day 17 chick embryo sterna and
grown in culture up to passage 4 by weekly subculturing.
APase activity was monitored at each passage. We found
that, as expected, APase activity had increased about
threefold in control cultures between passage 2 and 3, a re-
flection of the ongoing and advancing maturation process
(Fig. 8 A). In line with our hypothesis, we found that such
increase had also occurred in ch-ERG but not in C-1-1–
infected cultures (Fig. 8 A). In older passage 4 cultures, we
again observed that APase activity had increased further
in control and that no detectable APase was seen in C-1-1
cultures. Unexpectedly, however, APase activity in ch-
Figure 5. In situ hybridization analysis of gene expression in day
10 chick embryo fibula. Longitudinal sections of fibula and sur-
rounding tissues from C-1-1 virus-infected embryos were pro-
cessed for in situ hybridization with indicated probes. (A) Phase
micrograph; (B) type II collagen hybridization, showing a charac-
teristic strong signal in epiphysis and metaphysis and a much re-
duced signal in hypertrophic diaphysis; (C) type X collagen hy-
bridization, showing strong signal in hypertrophic diaphysis; and
(D) hybridization with common ch-ERG/C-1-1 probe, showing
lack of signal in fibula but extremely strong signal in surround-
ing perichondrial and connective tissues. Bar, 200 mm.The Journal of Cell Biology, Volume 150, 2000 34
ERG cultures now exceeded that in control by nearly two-
fold (Fig. 8 A).
Because APase activity is associated with the mineral-
ization phase of the maturation process (Ali et al., 1970),
we asked whether the very large increase in APase activity
in late passage ch-ERG cultures may be associated with
mineral deposition in the extracellular matrix. Confluent
passage 4–5 cultures of control, ch-ERG, and C-1-1 chon-
drocytes in microwell plates were grown for four addi-
tional days in medium containing 25 mg/ml ascorbate, an
additive needed for mineralization in culture (Leboy et al.,
1989). Cultures (in duplicate) were then processed for his-
tochemical detection of mineral, using alizarin red or von
Kossa stains. Indeed, we found that while some mineral
was present in control cultures, much larger amounts of it
were present in ch-ERG cultures (Fig. 8 B). In agreement
with the antimaturation ability of C-1-1 demonstrated
above, we found that mineral was completely absent in C-1-1
cultures (Fig. 8 B).
Discussion
In this study, we have demonstrated that developing chick
limb skeletal elements express two variants of the tran-
scription factor ERG, the full-length ch-ERG previously
described by Dhordain et al. (1995) and a novel shorter
variant (C-1-1) lacking a 27–amino acid segment located
z80 amino acid upstream of the DNA-binding ETS do-
main. We demonstrate that the gene expression patterns
and biological activities of ch-ERG and C-1-1 are distinct.
C-1-1 characterizes developing epiphyseal articular chon-
drocytes, whereas ch-ERG is preferentially expressed by
prehypertrophic chondrocytes in the growth plate and to a
lesser extent by articular chondrocytes. When constitu-
tively expressed, C-1-1 maintains chondrocytes in an im-
mature and phenotypically stable phenotype, blocks their
progression into type X collagen- and APase-rich hyper-
trophic chondrocytes, and induces expression of tenascin-C, a
unique trait of articular and immature chondrocytes. In addi-
tion, C-1-1 blocks endochondral ossification and marrow in-
vasion and the formation of an intramembranous bone collar.
In comparison, when constitutively expressed in vitro, ch-
ERG promotes chondrocyte development and expression of
functions associated with the terminal phases of maturation,
namely APase activity and mineral deposition in the extracel-
lular matrix. The data indicate that C-1-1 and ch-ERG partic-
ipate, and have distinct roles, in limb skeletogenesis. Because
of its expression patterns and its powerful and distinct biolog-
ical activity, C-1-1 may be instrumental in the genesis of artic-
ular chondrocytes and in the acquisition and maintenance by
these cells of their most important feature, a stable and im-
mature phenotype. On the other hand, given its ability to
promote chondrocyte maturation in vitro and its weak
activity in vivo, ch-ERG may have auxiliary roles in skele-
togenesis and may be one among several factors that facil-
itate completion of chondrocyte maturation and transition
from mineralized hypertrophic cartilage to endochondral
bone.
Figure 6. Immunohistochemical analysis of tenascin-C distribution. Longitudinal sections from control (A and C) and C-1-1 virus-
infected (B and D) day 10 chick embryo tibiotarsus and metatarsus were reacted with chick tenascin-C monoclonal antibody and
processed for immunofluorescence. Arrows in (A) and (C) point to tenascin-C present in epiphyseal articular layer in control tissue. (E
and F) Phase micrographs of epiphyseal portion of control (E) and C-1-1 virus-infected (F) metatarsus. Bars: (A–D) 250 mm; (E and F)
100 mm.Iwamoto et al. ERG Factors and Chondrocyte Diversification 35
Figure 8. C-1-1 and ch-ERG effects on alkaline phosphatase ac-
tivity and mineralization. (A) Histograms showing changes in al-
kaline phosphatase activity in control, ch-ERG virus-infected
and C-1-1 virus-infected cultures at passage 2, 3, and 4. (B) His-
tochemical detection of mineral. Duplicate P4 microwell control
and infected cultures were stained with mineral-specific alizarin
red or von Kossa stains.
Development of Articular and Growth
Plate Chondrocytes
As pointed out in the introduction, while the understand-
ing of articular chondrocyte development is quite limited
at present, there is a large body of information on the de-
velopment of growth plate chondrocytes. Thus, it has
become apparent that the progression of growth plate
chondrocytes through the resting, proliferative, prehyper-
trophic, hypertrophic, and mineralizing phases of matura-
tion is regulated by a number of powerful factors and mol-
ecules, including insulin-like growth factors, fibroblast
growth factors, bone morphogenetic proteins, hedgehog
proteins, and retinoids (Colvin et al., 1996; Vortkamp et
al., 1996; Enomoto-Iwamoto et al., 1998; Koyama et al.,
1999). It is of interest that these various factors and mole-
cules have contrasting effects on chondrocyte maturation.
For instance, fibroblast growth factors and their tyrosine
kinase receptors are found to exert a negative role on both
chondrocyte proliferation and progression toward the hy-
pertrophic stage (Colvin et al., 1996; Naski et al., 1998;
Sahni et al., 1999). On the other hand, we have shown that
endogenous retinoids and their nuclear receptors play a
positive role on maturation and are required for chondro-
cyte hypertrophy, mineralization, and endochondral ossifi-
cation (Koyama et al., 1999). Together, these studies have
clearly indicated that the maturation process of growth
plate chondrocytes is regulated by a fine balance between
negative and positive mechanisms; that is, mechanisms
that oppose maturation and mechanisms that favor it.
It follows that the development of articular chondro-
cytes may require a shift in such balance in favor of nega-
tive mechanisms, so that the maturation process would be
effectively and irreversibly blocked and the cells would
maintain a stable and immature phenotype through life
(Pacifici et al., 1990). C-1-1 and ch-ERG may represent
one example of such a shift. We show that these factors are
expressed in both the articular layer and growth plate, but
at very different ratios. In the articular layer the C-1-1/ch-
ERG expression ratio is z2.8, whereas in the growth plate
it is z0.8. Thus, by being more strongly expressed in the
articular layer, C-1-1 may be able to exert an effective an-
timaturation action, maintain the cells in an immature
stage, and participate in the regulation of traits character-
istic of that stage; these traits include a small cell size, low
Figure 7. C-1-1 and ch-ERG effects on chondrocyte behavior
and development in culture. (A) Northern blot analysis of tenas-
cin and aggrecan (AG) gene expression in passage 1 (P1) to pas-
sage 5 (P5) caudal sternal chondrocyte cultures infected with in-
sert-less virus (Control), ch-ERG virus (ch-ERG) or C-1-1 virus
(C-1-1). (B) Immunofluorescence micrographs of control (left)
and C-1-1 virus-infected (right) P2 cultures stained with tenascin-C
monoclonal antibody. (C) Western blots to determine ch-ERG
and C-1-1 content in nuclei from control, ch-ERG virus-infected
and C-1-1 virus-infected cultures. Affinity-purified antibodies re-
acting to all ERG proteins (lanes 1–3) or antibodies specific for
ch-ERG (lanes 4–6) were used. The major stained protein band
in lanes 2 and 5 displays the expected ch-ERG size of z55 kD
(see Dhordain et al., 1995), and the major band in lane 3 corre-
sponds to C-1-1 and thus migrates slightly faster than ch-ERG.
Note that the minor faster migrating band in lanes 2 and 5 likely
represents a degradation product of ch-ERG. Bar, 60 mm.The Journal of Cell Biology, Volume 150, 2000 36
APase activity, lack of type X collagen synthesis, lack of
matrix mineral deposition, and strong tenascin-C synthe-
sis. On the other hand, a shift in the C-1-1/ch-ERG expres-
sion ratio to z0.8 in the growth plate, combined with pref-
erential expression of these factors at such a ratio in the
prehypertrophic zone (see Figs. 1 D and 2 F), may produce
a change in biological activity, with ch-ERG becoming
preponderant and exerting a promaturation effect.
An important cytological characteristic of developing
articular chondrocytes is that the cells are round in shape,
whereas the underlying proliferative growth plate chon-
drocytes are flat and variously shaped (Howlett, 1979;
Lutfi, 1974; Shimazu et al., 1996). In addition, articular
chondrocytes are surrounded by abundant amounts of ten-
ascin-C, whereas the growth plate chondrocytes are tenas-
cin-C negative (Pacifici et al., 1993; Savarese et al., 1996).
We have shown here that C-1-1 misexpression induces
broader and higher expression of tenascin-C; this is ac-
companied by alterations in chondrocyte morphology,
with most cells exhibiting a roundish-to-oval morphology.
Thus, C-1-1 appears to be able to directly or indirectly in-
duce two features, i.e., a round cell shape and tenascin-C
synthesis, which normally distinguish articular chondro-
cytes from underlying growth plate chondrocytes and
which may be critical for the genesis of articular chondro-
cytes themselves. In other cell types, tenascin-C plays an
antiadhesive role and cells plated onto tenascin-C–coated
substrates remain round (Erickson, 1993). The protein
could have a similar role in articular chondrocytes; if so,
induction of tenascin-C and a round cell configuration
would be causally linked and dependent on C-1-1 action.
An additional point deserves to be made with regard to
tenascin-C induction by C-1-1. Other known negative
modulators of the maturation process we tested, including
Ihh, PTHrP and FGF-2, failed to induce tenascin-C gene
expression in cultured chondrocytes. This finding is actu-
ally not surprising in view of the fact that Ihh and PTHrP,
but not tenascin-C, are normally expressed in the growth
plate (Vortkamp et al., 1996). Thus, our finding suggests
an important implication: the antimaturation mechanisms
such as those due to C-1-1, which allow developing epiphy-
seal articular chondrocytes to acquire and maintain a sta-
ble immature phenotype, may be different from those
serving as negative modulators of maturation rates in
growth plate chondrocytes.
Ets Factors and Limb Development
Our results complement well and extend previous work on
the roles of ets factors in limb skeletogenesis. In situ hy-
bridization studies in chick showed that ERG transcripts
are first present in the prechondrogenic mesenchymal cell
condensations in the early limb (Dhordain et al., 1995) and
subsequently at sites of future joint development (Ganan
et al., 1996; Macias et al., 1997). Related studies showed
that in mouse embryo limbs another member of the ets
family, ETS-2, is expressed throughout the mesenchyme
and then becomes restricted to differentiated chondro-
cytes (Maroulakou et al., 1994), and that ETS-2 misexpres-
sion in transgenic mice leads to severe skeletal defects
(Sumarsono et al., 1996). It was not established in these
studies whether the ERG expressed in the mesenchy-
mal condensations is ch-ERG, C-1-1 or another variant,
whether ERG or its variants are expressed by interzone
cells, which constitute the primordial joint and give rise to
several joint structures (Mitrovic, 1978), and whether
ETS-2 is expressed by every chondrocyte present in long
bone anlagen or is expressed only by specific populations.
Nonetheless, it is clear from these studies and our data
that at least two members of the ets family, ETS-2 and
ERG, participate in limb skeletogenesis and that their
functions are likely to be important and exerted at multi-
ple stages of the process. Thus, the early, partially overlap-
ping expression of ERG and ETS-2 in limb mesenchyme
suggests that these factors may first cooperate in the cyto-
differentiation process of condensed mesenchymal cells
into chondrocytes. The subsequent, more distinct patterns
of expression indicate that ERG and ETS-2 may start act-
ing more independently, with ERG having a role in the
onset of joint formation and ETS-2 operating in differenti-
ated chondrocytes. Finally, our results indicate that ERG
variants may ultimately play regionally specialized roles
within each skeletal anlage.
Ets factors regulate transcription by forming hetero-
dimeric complexes with family members or other tran-
scription factors (Wasylyk et al., 1993, 1998; Graves, 1998).
ETS-2 and ERG strongly interact with each other and can
individually interact with c-Fos/c-Jun, producing hetero-
typic complexes with diverse biological activities and spec-
ificities (Butticé et al., 1996; Basuyaux et al., 1997). Inter-
estingly, c-Fos, c-Jun, and other AP-1 complex members
are expressed by both immature and hypertrophic chick
chondrocytes, with c-Jun expression levels higher in imma-
ture than mature cells; in addition, virally driven misex-
pression of c-Fos or c-Jun in cultured chondrocytes and in
the limb inhibits maturation and long bone development
(Kameda et al., 1997; Watanabe et al., 1997), precisely as
C-1-1 misexpression does. Thus, it is plausible that the bio-
logical functions of C-1-1 and ch-ERG in skeletogenesis
involve interactions with ETS-2 and c-Fos/c-Jun. In partic-
ular, given the similar phenotypic consequences of their
misexpression, C-1-1 and c-Fos/c-Jun may interact to
maintain chondrocytes in an immature state and induce
expression of traits characteristic of that state, such as te-
nascin-C. In preliminary studies (to be reported else-
where), we have found that virally driven C-1-1 expression
induces strong activity of a tenascin-C gene promoter-
reporter construct, indicating that C-1-1 acts on the pro-
moter directly. We have also found that the tenascin-C
promoter contains a small element around position –300
that includes an ets consensus site adjacent to an AP-1 site;
this element is reminiscent of biologically active ERG/AP-
1–responsive element previously identified in other genes,
such as that in the mammalian collagenase 1 gene (Butticé
et al., 1996). Thus, such an element may similarly regulate
tenascin-C gene expression in articular chondrocytes via
interaction with C-1-1/c-Fos/c-Jun complexes.
Structural Basis of ERG Function
Work in mammalian systems has shown that ERG is most
closely related to certain members of the ets gene family,
including ETS-1, ETS-2, FLI 1, and GABPa (Wasylyk et
al., 1997, 1998). All these factors are found to contain do-Iwamoto et al. ERG Factors and Chondrocyte Diversification 37
mains upstream and downstream of the ETS DNA-bind-
ing domain (see schematic in Fig. 9 A) that modulate the
factors’ transcription activation abilities. The ETS domain,
termed domain E, is located in the carboxyl half of the
protein and contains a winged helix-loop-helix responsible
for DNA binding. Domains A and C are transcriptional
activator domains, domain B contains a helix-loop-helix
thought to mediate protein–protein interactions (Seth and
Papas, 1990), and domains D and F are regulators of DNA
binding. For example, deletion of domain F reduces the
ability of human ERG-1 and ERG-2 to activate ets motif-
containing reporter constructs by .65% (Siddique et al.,
1993).
ch-ERG shares .95% identity in amino acid sequence
with its human counterpart ERG-3 (Dhordain et al., 1995)
and thus, the structural organization of ch-ERG is un-
doubtedly quite similar to that of mammalian ERG as well
as that of the other ets members above. What could then
be the possible structural reasons for the significantly dif-
ferent biological properties of ch-ERG and C-1-1 we dem-
onstrate here? The 27–amino acid segment present in ch-
ERG and absent in C-1-1 represents the amino half of do-
main C (Fig. 9 A). Preliminary computer-based models of
the secondary structure of domains B, C, and D in ch-
ERG and C-1-1 are shown in Fig. 9 B. Both domains B
and D are predicted to have a globular structure, whereas
domain C has an extended configuration. In ch-ERG, do-
main C protrudes away from domains B and D and dis-
plays two close turns. Instead, domain C in C-1-1 (indi-
cated as C1 in Fig. 9 B) is obviously much smaller and
contains a readily apparent antiparallel b-sheet with a sin-
gle turn. In addition, the overall spatial arrangement of
domains B, C, and D seems to be different in C-1-1 and ch-
ERG; the domains appear to be closer to, and more
aligned with, each other in C-1-1 than ch-ERG. Obviously,
these models await experimental validation. Nonetheless,
they suggest that the predicted significant differences in
domain C could have short- and long-range repercussions
on the proteins, possibly altering protein-protein and pro-
tein-DNA properties and leading to the diverse biological
properties of ch-ERG and C-1-1. Domains of ets factors,
including domain C, have been shown to be targets of
phosphorylation (Rabault and Ghysdael, 1994; Wasylyk et
al., 1997). If domain C in ERG turns out to be a similar
target and if the presence or absence of the 27–amino acid
segment affects phosphorylation, this pathway could also
contribute to the diverse biological properties of ch-ERG
and C-1-1.
We should mention that previous studies on human
ERG-1, ERG-2 and ERG-3 found no major functional
differences among these alternatively spliced variants
(Duterque-Coquillaud et al., 1993; Prasad et al., 1994).
The proteins exhibited similar DNA-binding affinity and
similar ability to transactivate ets motif-containing re-
porter constructs. These observations would appear to dis-
agree with our findings, but they probably do not. First,
since the mammalian counterpart of C-1-1 has not yet
been cloned, it was not included in the comparative analy-
sis of ERG-1, ERG-2, and ERG-3. Second, it is possible
that ERG-1, ERG-2, and ERG-3 may actually possess dis-
tinct biological properties, which, however, are not re-
vealed by DNA binding and transactivation of reporter
constructs. Biological assays more faithful to the in vivo
situation may be required to reveal functional differences
among variants, such as those used in our study or in stud-
ies of other ets variants (Melet et al., 1996).
In conclusion, the data in our study provide evidence
that C-1-1 may have an important role in the genesis and
function of articular chondrocytes. As far as we know, this
Figure 9. (A) Schematic of the domain structure of ch-ERG and
C-1-1, modeled after Wasylyk and Nordheim (1997). (B) Pre-
dicted secondary structure of domains B, C and D in ch-ERG
and C-1-1. The structurally different domain C in C-1-1 is indi-
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is the first transcription factor that, by virtue of its expres-
sion patterns and distinct biological activity, has been
linked to the development of these cells. Ongoing work
should provide details on how C-1-1 exerts this important
cellular role and in turn, contributes to the formation and
life-long function of diarthrodial joints.
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